Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Complete vs Walgreen's Lubricant Balance in Dry Eye
NCT06219577Phase 4Completed
- Sponsor
- Scripps Poway Eyecare and Optometry
- Start
- Jan 2024
- Primary completion
- Apr 2024
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of propylene glycol-hydroxypropyl guar nanoemulsion in dry eye syndrome (DED) (2 arms), sponsored by Scripps Poway Eyecare and Optometry. Primary endpoint: Symptom Assessment in Dry Eye Questionnaire at 2 weeks. Started Jan 2024; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06219577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06219577.